If your asthma keeps slipping out of control, your nose runs in damp rooms, or your child wheezes more in the summer and fall, an invisible mold could be part of the problem. Penicillium is one of the most common indoor fungi, and the immune system can react to its proteins the same way it reacts to pollen or dust mites.
This test looks for IgE (immunoglobulin E, the antibody class that drives allergies) targeted specifically at Penicillium notatum. A positive result means your body has been sensitized to this mold, which can fuel airway inflammation, asthma flares, and allergic rhinitis even when standard testing looks unremarkable.
IgE is an antibody protein made by B cells and plasma cells (the immune cells that produce antibodies) after exposure to an allergen. When you breathe in Penicillium spores, sensitized immune cells generate IgE that latches onto the mold's proteins. That IgE then binds to mast cells and basophils (immune cells that release inflammatory chemicals), and the next exposure triggers the symptoms you feel as allergy: congestion, wheezing, itching, or worse asthma.
Some Penicillium proteins, such as the protease Pen c 13, can also directly damage the lining of your airways and push your immune system toward a type-2 allergic response (the inflammation pattern behind most asthma and hay fever). This test does not measure mold in your home or in your body. It measures whether your immune system has built a specific allergic memory to it.
This is where Penicillium IgE has the strongest signal. In a study of 160 adults with asthma, sensitization to Penicillium and Aspergillus was independently linked to poor asthma control on a standard symptom score, while sensitization to dust mites or pollens was not. In a cohort of 121 adults with severe asthma, 29% were sensitized to Penicillium notatum by skin testing, blood testing, or both.
In children, the signal is similar. Mold-specific IgE positivity has been linked to more severe asthma, more frequent wheeze, and worse symptoms in summer and fall when outdoor mold spore counts climb.
What this means for you: if your asthma is harder to control than it should be on standard inhalers, finding hidden mold sensitization can change the conversation. It opens the door to environmental remediation, allergen avoidance, and, in select cases, treatment paths that target the underlying allergic biology rather than just the symptoms.
Mold sensitization shows up in allergic rhinitis (hay fever) too, especially in damp environments. In a Chinese study of more than 7,000 people with self-reported allergic rhinitis, Penicillium notatum testing was needed in the minimum screening panel to capture more than 96% of sensitized patients in central China, even though Penicillium positivity itself was relatively low. Leaving it out of testing missed real cases.
In a study of 508 adults with chronic obstructive pulmonary disease (a long-term lung condition often caused by smoking), sensitization to Penicillium and other fungi clustered together and was more common in people who had frequent flare-ups. Mold IgE is not a screening test for COPD, but if you already have it and exacerbate often, knowing your fungal sensitization profile may help explain why.
In a study of 100 people with atopic dermatitis (eczema), sensitization to Penicillium components was uncommon and did not track with disease severity, asthma, or rhinitis. If you have eczema without significant respiratory symptoms, this test is unlikely to be the most useful next step.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| About 1.65 million Americans tested for fungal allergy | Penicillium chrysogenum IgE positivity rate | Roughly 1 in 10 tested positive (about 10.7%) |
| 121 adults with severe asthma | Penicillium notatum sensitization by skin and blood test | Roughly 1 in 3 were sensitized (29%) |
| 100 adults with atopic dermatitis | Penicillium component sensitization | Low and not linked to skin disease severity |
Sources: Kwong et al. 2023; O'Driscoll et al. 2009; Celakovska et al. 2021.
What this means for you: a positive result is more meaningful when paired with symptoms or known mold exposure. A high prevalence in tested populations does not mean everyone with a positive result is symptomatic, but in someone who is already wheezing, congested, or hard to control, the finding becomes actionable.
There are no universally agreed clinical cutpoints for Penicillium notatum IgE that map cleanly to asthma flares or specific outcomes. Most labs report results in kU/L (kilounits per liter, a measure of antibody concentration) and use a general allergen-specific IgE class system. The thresholds below are the standard interpretive convention used widely in commercial allergy testing, not values derived from outcome studies of Penicillium specifically.
| Tier | Range (kU/L) | What It Suggests |
|---|---|---|
| Negative | Below 0.10 | No detectable sensitization |
| Low | 0.10 to 0.70 | Low-level sensitization, may or may not be clinically relevant |
| Moderate | 0.70 to 17.5 | Moderate sensitization, often clinically meaningful in symptomatic people |
| High | Above 17.5 | Strong sensitization, more likely to drive symptoms with exposure |
Compare results within the same lab over time for the most meaningful trend. Different assay platforms can produce different absolute numbers for the same sample.
A single Penicillium IgE result is a snapshot, not a verdict. IgE levels can shift with allergen exposure, environmental remediation, immunotherapy, and time away from the trigger. If you are sensitized and pursuing changes (fixing a damp basement, moving, starting allergen immunotherapy), retesting in 6 to 12 months can help you see whether your immune memory of this mold is fading or staying put.
For most people, a baseline test followed by a repeat in 6 to 12 months if you are making changes, then annually if symptoms persist, is a reasonable rhythm. Track the number alongside how you feel and how often you need rescue medication. The trajectory matters more than any single value.
A positive Penicillium IgE on its own does not diagnose mold allergy. It tells you your immune system recognizes the mold; pairing it with your symptoms and exposure history is what makes the result useful.
A few situations can complicate interpretation of any allergen-specific IgE result. If your total IgE is very high (above 1,000 IU/mL), individual specific IgE results may need to be interpreted in that context, since broad polyclonal elevation can shift the picture. Conversely, many people with real mold-related symptoms have normal total IgE, so a normal total does not rule out a meaningful specific result. Skin testing and blood IgE testing for individual molds agree only 14 to 56% of the time, so a single negative test does not fully exclude sensitization.
Evidence-backed interventions that affect your Penicillium Notatum Mold IgE level
Penicillium Notatum Mold IgE is best interpreted alongside these tests.